- Report
- February 2024
- 117 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- January 2023
- 116 Pages
Global
From €4317EUR$4,500USD£3,708GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$3,908USD£3,112GBP
The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are typically performed in a laboratory setting and can provide valuable information to healthcare providers.
The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less Read more